686 related articles for article (PubMed ID: 27793755)
1. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
Balguri SP; Adelli GR; Majumdar S
Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755
[TBL] [Abstract][Full Text] [Related]
2. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
Liu R; Liu Z; Zhang C; Zhang B
J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
[TBL] [Abstract][Full Text] [Related]
4. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
[TBL] [Abstract][Full Text] [Related]
5. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
[TBL] [Abstract][Full Text] [Related]
6. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.
Hippalgaonkar K; Adelli GR; Hippalgaonkar K; Repka MA; Majumdar S
J Ocul Pharmacol Ther; 2013 Mar; 29(2):216-28. PubMed ID: 23421502
[TBL] [Abstract][Full Text] [Related]
8. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
10. Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications.
Youssef AAA; Dudhipala N; Majumdar S
Int J Nanomedicine; 2022; 17():2283-2299. PubMed ID: 35611213
[TBL] [Abstract][Full Text] [Related]
11. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
12. Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.
Sharma AK; Sahoo PK; Majumdar DK; Sharma N; Sharma RK; Kumar A
Drug Deliv; 2016 Nov; 23(9):3364-3373. PubMed ID: 27128623
[TBL] [Abstract][Full Text] [Related]
13. Chitosan based nanocarriers for indomethacin ocular delivery.
Badawi AA; El-Laithy HM; El Qidra RK; El Mofty H; El dally M
Arch Pharm Res; 2008 Aug; 31(8):1040-9. PubMed ID: 18787795
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
15. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
16. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
17. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution.
Liu D; Li J; Cheng B; Wu Q; Pan H
Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.
Khalil RM; Abd-Elbary A; Kassem MA; Ghorab MM; Basha M
Pharm Dev Technol; 2014 May; 19(3):304-14. PubMed ID: 23528038
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
20. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]